Instill 1 drop in the affected eye(s) once daily.
SPECIAL POPULATION: Pediatric Population: The safety and efficacy of TAPCOM in children and adolescents below the age of 18 years have not been established. No data are available. TAPCOM is not recommended for use in children and adolescents below the age of 18years.
Use in Renal/Hepatic Impairment: Tafluprost and timolol ophthalmic solutions have not been studied in patients with renal/hepatic impairment and TAPCOM should therefore be used with caution in such patients.